These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29537858)

  • 41. The authors reply.
    Annane D; Dellinger RP
    Crit Care Med; 2013 Dec; 41(12):e484. PubMed ID: 24275413
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock.
    Duranteau J; Sitbon P; Teboul JL; Vicaut E; Anguel N; Richard C; Samii K
    Crit Care Med; 1999 May; 27(5):893-900. PubMed ID: 10362410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Continuation of Statin Therapy and Vasopressor Use in Septic Shock.
    Zechmeister C; Hurren J; McNorton K
    Ann Pharmacother; 2015 Jul; 49(7):790-5. PubMed ID: 25896127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of duration of hypotension prior to norepinephrine initiation in medical intensive care unit patients with septic shock: A prospective observational study.
    Patel JJ; Kurman JS; Biesboer A; Taha H; Katz M; Szabo A; Simpson SQ; Jacobs ER
    J Crit Care; 2017 Aug; 40():178-183. PubMed ID: 28412642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of heptaminol hydrochloride for catecholamine weaning in septic shock.
    Bahloul M; Chaari A; Ben Mbarek MN; Kallel H; Bouaziz M
    Am J Ther; 2012 Jan; 19(1):e8-17. PubMed ID: 20720484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of hypotension in septic shock.
    Stewart JT
    Lancet; 1996 Mar; 347(9001):622-3. PubMed ID: 8596356
    [No Abstract]   [Full Text] [Related]  

  • 47. Mortality trends in U.S. adults with septic shock, 2005-2011: a serial cross-sectional analysis of nationally-representative data.
    Goto T; Yoshida K; Tsugawa Y; Filbin MR; Camargo CA; Hasegawa K
    BMC Infect Dis; 2016 Jun; 16():294. PubMed ID: 27301657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Noradrenaline as a vasoactive agent in septic shock.
    Tordoff SG; Thompson JL; Williams AW
    Intensive Care Med; 2000 May; 26(5):648. PubMed ID: 10923747
    [No Abstract]   [Full Text] [Related]  

  • 49. Resuscitation bundle compliance in severe sepsis and septic shock: improves survival, is better late than never.
    Coba V; Whitmill M; Mooney R; Horst HM; Brandt MM; Digiovine B; Mlynarek M; McLellan B; Boleski G; Yang J; Conway W; Jordan J;
    J Intensive Care Med; 2011; 26(5):304-13. PubMed ID: 21220270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock.
    van Haren FM; Rozendaal FW; van der Hoeven JG
    Chest; 2003 Dec; 124(6):2256-60. PubMed ID: 14665508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. One-size MAP does not fit all.
    Senussi MH
    Crit Care; 2015 May; 19(1):212. PubMed ID: 25947571
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of Pediatric Septic Shock With the Surviving Sepsis Campaign Guidelines and PICU Patient Outcomes.
    Workman JK; Ames SG; Reeder RW; Korgenski EK; Masotti SM; Bratton SL; Larsen GY
    Pediatr Crit Care Med; 2016 Oct; 17(10):e451-e458. PubMed ID: 27500722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vasoactive drug support in septic shock.
    Dries DJ
    Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
    [No Abstract]   [Full Text] [Related]  

  • 54. Vasopressin in septic shock.
    Russell JA
    Crit Care Med; 2007 Sep; 35(9 Suppl):S609-15. PubMed ID: 17713417
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine.
    Nguyen HB; Lu S; Possagnoli I; Stokes P
    J Intensive Care Med; 2017 Aug; 32(7):451-459. PubMed ID: 27189952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vasopressors for hypotensive shock.
    Lampard JG; Lang E
    Ann Emerg Med; 2013 Mar; 61(3):351-2. PubMed ID: 23026787
    [No Abstract]   [Full Text] [Related]  

  • 57. Vasopressin pressor hypersensitivity in vasodilatory septic shock.
    Landry DW; Levin HR; Gallant EM; Seo S; D'Alessandro D; Oz MC; Oliver JA
    Crit Care Med; 1997 Aug; 25(8):1279-82. PubMed ID: 9267938
    [No Abstract]   [Full Text] [Related]  

  • 58. Vasopressor for refractory septic shock: dexmedetomidine could help decrease norepinephrine requirements.
    Dargent A; Quintin L; Jacquier M; Fournel I; Quenot JP
    Minerva Anestesiol; 2020 Aug; 86(8):885-886. PubMed ID: 32538581
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of hypotension in septic shock.
    Whiteley SM; Dade JP
    Lancet; 1996 Mar; 347(9001):622. PubMed ID: 8596354
    [No Abstract]   [Full Text] [Related]  

  • 60. Norepinephrine in septic shock: when and how much?
    Hamzaoui O; Scheeren TWL; Teboul JL
    Curr Opin Crit Care; 2017 Aug; 23(4):342-347. PubMed ID: 28509668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.